ORiordan Anne 4
4 · Jazz Pharmaceuticals plc · Filed May 11, 2022
Insider Transaction Report
Form 4
ORiordan Anne
Director
Transactions
- Sale
Ordinary Shares
[F1]2022-05-09$148.92/sh−457$68,056→ 9,254 total - Sale
Ordinary Shares
[F1]2022-05-09$150.49/sh−9$1,354→ 9,245 total
Footnotes (1)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Signature
By: /s/Adam Guttmann, as attorney in fact For: Anne O'Riordan|2022-05-11